Nussenzweig, Michel C
- Rockefeller University · Microbiology & Immunology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #18,811
- Rising Star
- Sustained Excellence
- Long-Funded
- Mentor
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Microbiology & Immunology
NIH Funding · FY2023
Linked Award Amount
$634.7K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#18,811
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Nussenzweig, Michel C as a PI. Multi-PI records show the full award amount for context.
- 5R37AI037526-29R37Contact PIClass Switch Recombination in B LymphocytesRockefeller University · Microbiology & Immunology (NIH department code)$423.8Kaward amount
- 5T32AI070084-15T32Contact PIImmunity and Infectious DiseaseRockefeller University · Microbiology & Immunology (NIH department code)$211Kaward amount
Award organization
Organizations that administered FY2023 awards listing Nussenzweig, Michel C as a PI.
FY2023 award administered by Rockefeller University (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardRockefeller University
- 2007$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #8058
- 2008$2M Cumulative Funding
- 2009$5M Cumulative Funding
- 2009Entered Top 25% NationallyRanked #1912
- 2009Entered Top 10% NationallyRanked #1912
- 2011$10M Cumulative Funding
- 2019$25M Cumulative Funding